Skip to content

CINGLE-studie: Cochleaire Implantatie bij siNGLE-sided deafness

CINGLE-trial: Cochlear Implantation for siNGLE-sided deafness

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON26952
Enrollment
120
Registered
2014-05-06
Start date
2014-07-15
Completion date
Unknown
Last updated
2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

single-sided deafness, unilateral hearing loss, single-sided hearing loss, unilateral deafness, eenzijdige doofheid, unilaterale doofheid, eenzijdig gehoorverlies, unilateraal gehoorverlies

Interventions

Randomised: Cochlear Implantation (CI) versus Bone Conduction Device (BCD) or Contralateral Routing of Sound system (CROS)

Sponsors

Department of Otorhinolaryngology and Head & Neck Surgery University Medical Center Utrecht, Utrecht, The Netherlands
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: - Age 18 or older. - Acute onset of postlingual SSD, defined as onset unilateral hearing loss between ≥3 months and ≤10 years before time of inclusion. - Hearing measurements: > Pure Tone Audiometry of the deaf ear, defined as thresholds of 70 dB or higher on frequencies 0,5 – 4.0 kHz (average). > Normal hearing on the contralateral ear, defined as pure tone audiometry thresholds of 30 dB or less on frequencies 0.5 – 4.0 kHz (average). > Air bone gap 10 dB or smaller. - Normal function of middle ear (i.e. no acute middle ear infections or tympanic membrane perforations). - Dutch language proficiency. - Willingness and ability to participate in all scheduled procedures outlined in the protocol. - General health allowing general anaesthesia for the potential surgical implantation of a CI or BCD. - Patients covered by the Dutch health insurance. - Patients should agree to be implanted with a CI or BCD. - Informed consent understood, filled out and signed by patient. - Patients are not allowed to participate in another ongoing research study related to SSD or cochlear implantation

Exclusion criteria

Exclusion criteria: - previous experience with implanted BCD or CI - retrocochlear pathology - abnormal cochlear anatomy in one or both ears (i.e. ossification) - disability which could interfere with the completion of the tests (i.e. psychiatric problems or severe comorbidity with an expected survival of less than five years)

Design outcomes

Primary

MeasureTime frame
Performance on the modified Plomp hearing test.

Secondary

MeasureTime frame
- Performance on the Standard Dutch phoneme test (NvA-list)  - Speech intelligibility test with spatially separated sources  - Crescent of sound test, for sound localization  - Speech, Spatial and Qualities of hearing scale (SSQ) - Health Utilities Index (HUI3) - Glasgow Benefit Inventory (GBI) - Abbreviated Profile of Hearing Aid Benefit (APHAB) - Time Trade Off (TTO)  - Visual Analogue Scale (VAS) - EuroQol5D - Hospital Anxiety and Disorder Scale (HADS) - Tinnitus Handicap Inventory (THI) - Tinnitus Questionnaire (TQ) - Tinnitus Burden Questionnaire (TBQ) - Cost diary for cost utility analysis

Contacts

Public ContactH.P.M. Peters

Department of Otorhinolaryngology and Head & Neck Surgery, University Medical Center Utrecht, Huispost G05.129, Heidelberglaan 100

h.p.m.peters@umcutrecht.nl+31 88 75 56644

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)